Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Cancer Gene Therapy|July 2, 2003
Tissue distribution of liposome-mediated epidermal growth factor receptor antisense gene therapySufi M Thomas, Qing Zeng, Kevin F Dyer, et al.
The Annals of Thoracic Surgery|June 1, 1995
CABG after successful PTCA: a case-control studyR G Johnson, C Sirois, J F Watkins, et al.
Cancer Research|July 15, 1994
The human DNA repair gene, ERCC2 (XPD), corrects ultraviolet hypersensitivity and ultraviolet hypermutability of a shuttle vector replicated in xeroderma pigmentosum group D cellsE M Gözükara, C N Parris, C A Weber, et al.
Chemical Research in Toxicology|February 26, 1998
Change in the mode of inhibition of acetylcholinesterase by (4-nitrophenyl)sulfonoxyl derivatives of conformationally constrained choline analoguesP S Savle, R A Medhekar, E L Kelley, et al.
Circulation|June 1, 1991
Ultrasonic angioplasty in totally occluded peripheral arteries. Initial clinical, histological, and angiographic resultsU Rosenschein, L A Rozenszajn, L Kraus, et al.
American Journal of Hematology|May 20, 1999
Telomere length shortening is associated with disease evolution in chronic myelogenous leukemiaJ Boultwood, C Fidler, P Shepherd, et al.
Inorganic Chemistry|October 28, 2003
A solid-state spectral effect in eclipsed tetracyanonickelates: X-ray crystal structure, polarized specular reflectance spectroscopy, and ZINDO modeling of Sr[Ni(CN)4].5H2O, Rb2[Ni(CN)4].H2O, and Na2[Ni(CN)4].3H2OFrank R Fronczek, Terry J Delord, Steven F Watkins, et al.
Gene Therapy|January 11, 2000
TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivoS Endo, Q Zeng, N A Burke, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 1992
Photochemotherapy in human heart transplant recipients at high risk for fatal rejectionE A Rose, M L Barr, H Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2003
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growthPaul L Leong, Genevieve A Andrews, Daniel E Johnson, et al.
Pageof 14